3% LTX-109
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 3% LTX-109, covering 2021-08-30 to 2021-08-30. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of 3% LTX-109 for Nasal Decolonisation of Staphylococcus [Phase 1, Phase 2]